Gain Therapeutics, Inc. (GANX)
Nasdaq: GANX · CIK 0001819411 · United States
Every official Gain Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open GANX filings
Gain Therapeutics, Inc. documents
- Gain Therapeutics, Inc. 10-K 2026GANX 10-K 2026: annual report for fiscal 2026
- Gain Therapeutics, Inc. 10-K 2025GANX 10-K 2025: annual report for fiscal 2025
- Gain Therapeutics, Inc. 10-K 2024GANX 10-K 2024: annual report for fiscal 2024
- Gain Therapeutics, Inc. 10-K 2023GANX 10-K 2023: annual report for fiscal 2023
- Gain Therapeutics, Inc. 10-K 2022GANX 10-K 2022: annual report for fiscal 2022
- Gain Therapeutics, Inc. 10-Q 2026GANX 10-Q 2026: quarterly report for fiscal 2026
- Gain Therapeutics, Inc. 10-Q 2025GANX 10-Q 2025: quarterly report for fiscal 2025
- Gain Therapeutics, Inc. 10-Q 2024GANX 10-Q 2024: quarterly report for fiscal 2024
- Gain Therapeutics, Inc. 10-Q 2023GANX 10-Q 2023: quarterly report for fiscal 2023
- Gain Therapeutics, Inc. 10-Q 2022GANX 10-Q 2022: quarterly report for fiscal 2022
- Gain Therapeutics, Inc. 8-K 2026GANX 8-K 2026: current report for fiscal 2026
- Gain Therapeutics, Inc. 8-K 2025GANX 8-K 2025: current report for fiscal 2025
- Gain Therapeutics, Inc. 8-K 2024GANX 8-K 2024: current report for fiscal 2024
- Gain Therapeutics, Inc. 8-K 2023GANX 8-K 2023: current report for fiscal 2023
- Gain Therapeutics, Inc. 8-K 2022GANX 8-K 2022: current report for fiscal 2022
- Gain Therapeutics, Inc. DEF 14A 2026GANX DEF 14A 2026: proxy statement for fiscal 2026
- Gain Therapeutics, Inc. DEF 14A 2025GANX DEF 14A 2025: proxy statement for fiscal 2025
- Gain Therapeutics, Inc. DEF 14A 2024GANX DEF 14A 2024: proxy statement for fiscal 2024
- Gain Therapeutics, Inc. DEF 14A 2023GANX DEF 14A 2023: proxy statement for fiscal 2023
- Gain Therapeutics, Inc. DEF 14A 2022GANX DEF 14A 2022: proxy statement for fiscal 2022
- Gain Therapeutics, Inc. Form 4 2026GANX Form 4 2026: insider trading filing for fiscal 2026
- Gain Therapeutics, Inc. Form 4 2025GANX Form 4 2025: insider trading filing for fiscal 2025
- Gain Therapeutics, Inc. Form 4 2024GANX Form 4 2024: insider trading filing for fiscal 2024
- Gain Therapeutics, Inc. Form 4 2023GANX Form 4 2023: insider trading filing for fiscal 2023
- Gain Therapeutics, Inc. Form 4 2022GANX Form 4 2022: insider trading filing for fiscal 2022
- Gain Therapeutics, Inc. S-1 2026GANX S-1 2026: registration statement for fiscal 2026
- Gain Therapeutics, Inc. S-1 2025GANX S-1 2025: registration statement for fiscal 2025
- Gain Therapeutics, Inc. S-1 2024GANX S-1 2024: registration statement for fiscal 2024
- Gain Therapeutics, Inc. S-1 2023GANX S-1 2023: registration statement for fiscal 2023
- Gain Therapeutics, Inc. S-1 2022GANX S-1 2022: registration statement for fiscal 2022
- Gain Therapeutics, Inc. 13F 2026GANX 13F 2026: institutional holdings for fiscal 2026
- Gain Therapeutics, Inc. 13F 2025GANX 13F 2025: institutional holdings for fiscal 2025
- Gain Therapeutics, Inc. 13F 2024GANX 13F 2024: institutional holdings for fiscal 2024
- Gain Therapeutics, Inc. 13F 2023GANX 13F 2023: institutional holdings for fiscal 2023
- Gain Therapeutics, Inc. 13F 2022GANX 13F 2022: institutional holdings for fiscal 2022
More companies